FDA approves sildenafil oral film for men with erectile dysfunction

Sildenafil ODF offers ease of administration, accurate dosage, rapid bioavailability, and ease of carrying in pockets that has improved medication compliance compared to other formulations.

Additional information

Nevertheless, in spite of these challenges, ODFs have demonstrated significant potential in improving patient compliance and convenience, particularly in patients with swallowing difficulties. Further ongoing research and development in this sildenafil spray field could lead to significant innovations and advancements in drug delivery systems [Citation110,Citation111], Both ODTs and ODFs provide patient convenience and compliance compared to conventional solid dosage forms due to their rapid disintegration, dissolution, faster absorption, and enhanced bioavailability. With the availability of numerous modern technologies and careful selection of excipients, ODFs and ODTs provide excellent flexibility in drug design and aids in tailor-made precision medicine at lower doses. Sildenafil ODF, an innovative dosage form, can be used for the treatment of ED as it better addresses the unmet needs and expectations of men with ED. Sildenafil ODF showed unwavering performance that yields a consistent product, meeting all specifications at release and after three weeks of storage under stressed conditions (temperature up to 60°C).

2.1 Recommended Dosage

It offers unique and sustainable advantages to ED patients, including a pleasant mint taste, convenience, privacy, and storage options, making it the potential drug of choice and the most preferred formulation. Orodispersible films are a promising drug delivery system with several key trends and advancements. The emergence of innovative manufacturing techniques including 2D (two-dimensional) and 3D (three-dimensional) printing technologies helps in the incorporation of nanoparticles that can substantially improve drug delivery in coming years. ODFs can personalize therapy by specifically tailor-made therapy according to individual patient’s needs. This patient-centric approach improves the patient compliance that would be highly beneficial in early sildenafil uk price treatment and management of erectile dysfunction (ED). Studies have demonstrated bioequivalence and supports the interchangeability of new sildenafil ODF formulation with the marketed FCT formulation.

The results of stress test unveiled reliable performance of sildenafil ODF with acceptable physical

• Sildenafil strips are an alternative to traditional pill forms.
• The strips dissolve quickly, eliminating need for water to swallow.
• They are convenient for on-the-go use and discreet consumption.
• Possible side effects include headache, flushing, and dizziness.
• Sildenafil strips should be used approximately one hour before activity.
• Not suitable for individuals with certain health conditions; consult a doctor.
• They are typically used in men aged 18 and above.
• The medication works by increasing blood flow to the penis.
• Sildenafil strips can be part of a broader erectile dysfunction treatment plan.
• Side effects may vary depending on individual health status.
• Erectile response may improve with proper use and dosing.
• They are available through licensed pharmacies and online sources.

and chemical stability exemplifying the possibility to safely store the drug in the pocket.

Carefill 20mg Ods

Sildenafil citrate ODF with its distinctive efficacy and safety profile provides greater patient convenience of use without the need for water and through its rapid onset of action and enhanced bioavailability. This innovative drug formulation of sildenafil may help in recognition of its benefits in both prescribers and patients and effectively reduce the morbidity and mortality associated with ED and its comorbidities. In addition to the effective use of sildenafil citrate, various new advancements are emerging in the treatment of ED. These include but not limited to gene therapy, stem cell therapy, platelet-rich plasma, shock-wave therapy, amongst others. These developments aim to provide more effective and safer treatment alternatives for ED, potentially transforming its management in the near future.

5.6 Adverse Reactions with the Concomitant Use of Ritonavir

Erectile dysfunction (ED) is a potential biomarker of cardiovascular and peripheral vascular disease. Early identification and management of ED can effectively treat the initial symptoms and arrest the worsening of the disease and its comorbidities. Sildenafil citrate, a selective phosphodiesterase-5 inhibitor, is a first-line agent, approved and marketed by European union and USFDA. Its safety and efficacy profile is very well established and it has been used in effective management of ED, regardless of associated comorbidities. Orodispersible dosage forms are one of the novel drug delivery systems that are designed and developed to improve efficacy, safety, patient compatibility, and acceptance. The development of orodispersible formulation for sildenafil offers convenience and better addresses the needs and expectations of patients with ED.

5. Warnings and Precautions

Headache and flushing are the most commonly reported side effects [Citation101]. Sildenafil is supplied in both solid film-coated tablet (FCT) and orodispersible tablet formulations. The sildenafil ODT and ODFs are made available through implementation of innovative manufacturing technologies [Citation8,Citation102]. It is also offered as chewable tablets and an orally soluble orodispersible film formulation [Citation82]. conducted a randomized clinical trial that reported bioequivalence of sildenafil ODT with or without water compared to marketed film-coated tablets.

ORAL STRIPS

This study also identified the effect of food on the release pattern of drug and demonstrated the benefits of the administration of sildenafil ODT on empty stomach [Citation103]. examined and reported the bioequivalence of sildenafil citrate ODF and FCT with and without water in 2 randomized crossover studies [Citation75]. Owing to its unique pharmacological characteristics, quick disintegration within seconds, the novel sildenafil ODF is widely prescribed and preferred among ED patients. A study conducted in Japan surveyed 25 patients with ED regarding the ease of consumption and portability with the use of sildenafil ODF formulation. The survey items comprised (i) portability, (ii) storage techniques, (iii) ease of consumption, (iv) comfortableness, (v) extent of self-consciousness with their partner, (vi) thoughts on administering the film formulation, (vii) comparison with the tablets, and (viii) efficacy and adverse reaction. CRediT: Conceptualization: EAJ, TH, and SV; data curation: EAJ, TH, and SV; formal analysis: EAJ, TH, and SV; funding acquisition: EAJ; investigation: EAJ, TH, and SV; methodology: EAJ, TH, and SV; project administration: EAJ, TH, and SV; resources: EAJ, TH, and SV; software: EAJ, TH, and SV; supervision:

EAJ, TH, and SV; validation: EAJ, TH, and SV; visualization: EAJ, TH, and SV; writing – original draft: EAJ, TH, and SV; writing –

review and editing: EAJ, TH, and SV Writing and editorial support was provided by Mamatha K., PhD, and Shantha Kumar V., PhD, from Viatris.

• Sildenafil oral strips provide a non-invasive way to treat ED.
• They avoid swallowing pills, which some patients find difficult.
• Strips are often manufactured with pleasant flavors to enhance appeal.
• The medication’s effect can be influenced by food intake.
• Alcohol consumption may reduce effectiveness or increase side effects.
• Sildenafil strips should be used as prescribed and not mixed with other ED drugs.
• These strips are designed for quick absorption in the oral mucosa.
• Overuse or misuse can lead to adverse health effects.
• Proper dosing helps minimize risks of prolonged erections or priapism.
• Sildenafil strips do not cure ED but help manage symptoms.
• They may be used in combination with psychological or lifestyle interventions.
• Always check expiration dates before using sildenafil strips.

The original contributions presented in the study are included in the article, and further inquiries can be directed to the corresponding author.

• Sildenafil oral strips are a fast-acting form of erectile dysfunction medication.
• They are administered orally, dissolving quickly on the tongue for rapid effect.
• Sildenafil strips are often flavored to improve the user experience.
• They contain the same active ingredient as traditional sildenafil tablets.
• These strips are designed for people seeking discreet medication options.
• Onset of action for sildenafil strips can be within 15-30 minutes.
• Proper storage of sildenafil strips involves keeping them in a cool, dry place.
• Dosage strength varies, typically available in 25mg, 50mg, and 100mg.
• Using sildenafil strips without medical consultation is not recommended.
• They may interact with other medications like nitrates or alpha-blockers.
• Sildenafil oral strips are approved for the treatment of erectile dysfunction.
• Users should follow prescribed dosages for safety and effectiveness.

EAJ is a Professor of endocrinology and sexual medicine, University of Rome Tor Vergata, Rome, Italy.

Written By

ODFs are innovative and sophisticated drug delivery systems that disintegrate instantly in the mouth without the need for water. They unveil a prudent and easy mode of administration, with no risk of choking or inconvenience during swallowing. These attributes of ODFs improve compliance specifically in patients with dysphagia, and children and elderly population with comorbidities (e.g., renal impairment or congestive heart failure) when compared with conventional tablets or capsules. This noninvasive drug delivery system offers an altered clinical profile as it surpasses the enterohepatic circulation [Citation8]. Since the drug gets absorbed majorly from buccal mucosal tissues, it also reduces the risk of formation of toxic metabolites due to lowered hepatic metabolism [Citation106].

4.1 Nitrates

ODFs with their convenience, together with superior dosing accuracy and swift onset of action, have transpired in strong patient preference among various patient groups. Since each film or strip consists of precise quantities of the APIs and is devoid of physiological variability in the gastrointestinal tract, there is minimal intersubject variability in clinical response unveiled by ODFs [Citation107]. Given all these advantages, growing body of research illustrates that majority of patients and prescribers prefer orodispersible dosage forms over conventional oral solid dosage forms [Citation108,Citation109]. There are fewer limitations with ODFs such as complex manufacturing processes and requirement of specialized equipment that may significantly increase the production costs. Also, these innovative formulations may face different challenges compared to traditional dosage forms during application and regulatory approval processes, necessitating additional studies to evaluate safety, efficacy, and stability. He is a paid speaker for several pharmaceutical companies like Bayer, Ibsa, Menarini, Otsuyka, Recordati, Pfizer, and Viatris.

Created by Medical Techs

Of all the participants, 61.5% of the patients who switched from tablets to film quoted that storage and portability were improved and were comfortable during consumption. The study reported that most of their patients felt more at ease (69.2% who swapped from tablets to film and 75.0% belonged to the prescribed film-only category) and more comfortable with the film (61.5% who switched from tablets to film and 66.7% belonged to the prescribed film-only category). Mild hot flashes and headache were the only two adverse reactions with no severe adverse reaction reported by the study participants. The survey demonstrated improved ease of intake and portability with the orodispersible film compared to tablets [Citation104]. However, the efficacy of PDE5-Is has been thoroughly established, and the documented evidence reveals that a prominent proportion of patients discontinued this pharmacological therapy prematurely.

Robert Williams

There is a gradual dissatisfaction noticed with the prescribed therapy among patients despite their successful intercourse. Studies depict that approximately 50% of men abandon their treatment with PDE5-Is in conventional formulations within a year [Citation105]. There is an immense need to understand individual patient’s needs and expectations regarding treatment for ED and also to comprehend their personal experiences and preferences. This will be instrumental in deciphering successful patient outcomes and satisfaction regarding the pharmacological therapy [Citation8]. ODFs were developed to overcome the above drawbacks of conventional oral solid dosing forms and to significantly improve sildenafil 25mg tablets patients’ compliance and acceptability to the pharmacological therapy.